寻找细胞毒性异构醇衍生物的最终有价值的搜索
Julia Heisig1, Niels V Heise1, Sophie Hoenke1
1Organic Chemistry, Martin-Luther University Halle-Wittenberg, Kurt-Mothes, Str. 2, D-06120 Halle (Saale), Germany.
Molecules (Basel, Switzerland)
|July 14, 2023
概括
新的醇糖衍生物显示出强大的抗癌活性. 研究人员合成了异骨胺胺,并发现特定的罗达胺结合物,特别是具有同类皮帕拉津结合剂的,有效地向人类瘤细胞系.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 醇糖化物是天然的甜味剂,具有潜在的治疗应用.
- 伊索斯泰维醇是从石化中衍生出来的,可以作为化学修饰的多功能支架.
- 开发新的细胞毒剂对于癌症治疗至关重要.
研究的目的:
- 为了合成和评估基于异维醇的胺的细胞毒性活性.
- 研究这些化合物与人类瘤细胞系的结构-活性关系.
- 为了确定有前途的抗癌药物候选者.
主要方法:
- 乙酸的酸性水解产生异乙醇.
- 使用不同的链接剂和功能组制备各种异维醇胺.
- 细胞毒性测定使用人类瘤细胞系的面板.
- 基于细胞毒性数据的结构-活性关系分析.
主要成果:
- 大多数合成的异骨胺胺没有显著的细胞毒性活性.
- 含有 (同) 皮佩拉尼尔间隔剂和罗达胺B或101的异维醇合物显示出强烈的细胞毒性.
- 同型比拉津间隔衍生物比比拉津间隔衍生物更有效.
- 与罗达胺B杂交物相比,罗达胺101结合物表现出较高的细胞毒性.
- 在亚微分子度范围内观察到细胞毒性活性.
结论:
- 特定的异醇 - 罗达胺结合物对人类瘤细胞具有显著的细胞毒性潜力.
- 选择间隔剂 (homoiperazinyl > piperazinyl) 和罗达胺染料 (rhodamine 101 > rhodamine B) 会影响细胞毒性疗效.
- 这些发现突显出异骨醇衍生物作为开发新型抗癌剂的支架的潜力.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
985
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
985
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K


